this could be good...

UPDATE 2-US approves Acorda MS drug to help with walking | Reuters

Acorda Therapeutics Inc
(ACOR.O) won U.S. approval on Friday for the first drug to
improve walking ability in patients with multiple sclerosis.

MS patients in clinical trials who took the oral drug,
Ampyra, had faster walking speeds than others who got a
placebo, the Food and Drug Administration said in a statement.

Enhanced by Zemanta

No comments:

Post a Comment